Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.7488
+0.0688 (10.12%)
At close: Aug 22, 2025, 4:00 PM
0.7486
-0.0002 (-0.03%)
After-hours: Aug 22, 2025, 4:28 PM EDT
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $45.96 million as of August 22, 2025. Its market cap has increased by 181.24% in one year.
Market Cap
45.96M
Enterprise Value
33.30M
1-Year Change
181.24%
Ranking
Category
Stock Price
0.75
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $45.96M, a decrease of -63.91%. That is a compound annual growth rate of -26.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 41.73M | 304.69% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 639.05B |
| Johnson & Johnson | 431.91B |
| AbbVie | 372.74B |
| UnitedHealth Group | 270.80B |
| AstraZeneca | 250.11B |
| Novartis AG | 246.48B |
| Novo Nordisk | 239.90B |
| Abbott Laboratories | 230.56B |